TAIPEI (Taiwan News) — Taiwan’s Food and Drug Administration (TFDA) ordered SHS Biotech and HealthTake to recall its products containing red yeast rice (beni koji) on Monday (March 25).

Twenty-six people in Japan on Monday were hospitalized after taking supplements containing Japanese red yeast rice made by Kobayashi Pharmaceutical, Japan Times reported. The company said that it supplied the ingredient to approximately 50 companies, per NHK World-Japan.

Following these reports, the TFDA launched an investigation and found two Taiwanese companies were selling products containing the ingredient, per Liberty Times. The TFDA ordered the companies to remove products containing red yeast rice from shelves. Meanwhile, the government has halted the import of products containing the ingredient.

TFDA Deputy Director-General Lin Chin-fu (林金富) said that the two companies were importing the ingredient for use in capsules. As for the products themselves, the TFDA will track them down with help from local governments, he added.

The TFDA said that any companies using Kobayashi Pharmaceutical’s red yeast rice must stop using the ingredient, per CNA. Failure to report and continued use of red yeast rice will result in a fine between NT$30,000 (US$941) and NT$3,000,000 per Article 47 of the Act Governing Food Safety and Sanitation, the agency said.

Both SHS Biotech and HealthTake have issued statements on their websites, warning consumers to avoid buying their products containing red yeast rice and said no health issues have occurred from consumers using their products.